Effect van eiwitsupplementen op spierpijn en spierschade na een hardloopwedstrijd
Recruiting
- Conditions
- Delayed onset muscle soreness and muscle damage
- Registration Number
- NL-OMON22476
- Lead Sponsor
- Radboud University Medical Center Nijmegen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 416
Inclusion Criteria
Between 30 and 60 years of age
- Able to understand and perform the study procedures
Exclusion Criteria
Muscle soreness and muscle complaints in daily life (unrelated to exercise) upon enrolment
- Type I or type II diabetes
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method visual analogue scale (VAS) 24 hours post-race.
- Secondary Outcome Measures
Name Time Method Secondary study outcomes:<br /><br>o VAS score 48 and 72 hours post-race<br /><br>o Short-Form Brief Pain Inventory (BPI-SF))<br /><br>o Perceived soreness measured with a strain gauge algometer (subsample, n = 208)<br /><br>o Creatine Kinase (CK) and Lactate dehydrogenase (LDH) (muscle damage marker) (subsample, n = 208)<br /><br>o Short-Form Brief Fatigue Inventory (BFI-SF)